Contraception

Contraception as a High-Yield Clinical Domain

Contraception encompasses the methods and devices used to prevent pregnancy, which is a core component of women's health primary care. For the Family Nurse Practitioner (FNP) exam, understanding the efficacy, mechanisms, prescribing considerations, and contraindications of each contraceptive method is a high-yield area.[1] Mastery of this topic allows FNPs to provide patient-centered counseling, prescribe appropriately, and manage common side effects across the reproductive lifespan.

Clinically, this topic matters because nearly half of all pregnancies in the United States are unintended, and the FNP is often the primary provider responsible for initiating and managing contraception.[2] Exam questions frequently test your ability to match a patient's medical history (e.g., migraine with aura, obesity, smoking status) with the safest and most effective contraceptive option.

Standardized Terminology and Efficacy Metrics

  • Perfect-Use Failure Rate: The pregnancy rate when a method is used consistently and correctly every time (e.g., <1% for IUDs, implants).
  • Typical-Use Failure Rate: The pregnancy rate among average users who may not use the method consistently (e.g., ~9% for oral contraceptive pills).
  • Contraceptive Efficacy (Pearl Index): Number of pregnancies per 100 woman-years of use. Lower index = higher efficacy.
  • LARC (Long-Acting Reversible Contraception): IUDs and the implant. These are Tier 1 methods due to very low failure rates and high continuation rates.[3]
  • Emergency Contraception (EC): Methods used after unprotected intercourse to prevent pregnancy. Includes ulipristal acetate, levonorgestrel, and the copper IUD.
  • US MEC (U.S. Medical Eligibility Criteria for Contraceptive Use): CDC guidelines that categorize conditions (1-4) to determine if a contraceptive method is safe for a specific patient.[1]
  • CHC (Combined Hormonal Contraception): Contains both estrogen and progestin (pills, patch, ring). Estrogen component carries thrombotic risk.
  • POP (Progestin-Only Pills): Also called the "mini-pill." No estrogen; safer in patients with migraine with aura or hypertension.

Mechanisms of Action and Efficacy Tiers

Mechanisms of Action

  • Combined Hormonal Methods (Pill, Patch, Ring): Suppress ovulation (primary mechanism); thicken cervical mucus; alter endometrial lining.[4]
  • Progestin-Only Methods (POP, Implant, LNG-IUS, DMPA): Thicken cervical mucus (primary); may suppress ovulation variably; thin endometrium.
  • Copper IUD: Creates a sterile inflammatory response in the uterus that is toxic to sperm; prevents implantation.
  • Barrier Methods (Condoms, Diaphragm): Physically block sperm from reaching the cervix.
  • Fertility Awareness-Based Methods (FABMs): Tracking fertile window and avoiding unprotected intercourse during that time.

Tier-Based Efficacy (WHO & CDC Classifications)

  1. Tier 1 (Most Effective): Implant, Copper IUD, LNG-IUS, Female Sterilization. Failure rate <1 pregnancy per 100 women in 1 year.
  2. Tier 2 (Moderately Effective): DMPA injection, POP, CHC pills/patch/ring. Failure rate 6-12 per 100 women in 1 year.
  3. Tier 3 (Least Effective): Male condoms, diaphragm, cervical cap, spermicides, fertility awareness. Failure rate 18-28 per 100 women in 1 year.

Quick-Start Method

The FNP can initiate hormonal contraception on the same day as the visit, provided it is reasonably certain the patient is not pregnant. A negative urine pregnancy test and a reliable history (e.g., no unprotected sex since last normal menses) are sufficient. This improves access and reduces unintended pregnancy.[5]

Contraindications and Common Side Effects

While contraception itself is not a disease state, the FNP must recognize contraindications and side effects associated with each method. These are frequently tested on exams.

  • CHC Contraindications (remember "ACHES" for side effects, "SAFE" for contraindications):
    • Smoking >15 cigs/day AND age ≥35 years
    • Age ≥35 + migraine with aura
    • Hypertension (systolic ≥160 or diastolic ≥100)
    • History of DVT/PE or known thrombophilia
    • Breast cancer (current)
    • Cirrhosis or active hepatitis
    • Migraine with aura (any age) — this is a US MEC Category 4[1]
  • DMPA (Depot-Medroxyprogesterone Acetate) Warnings:
    • Bone mineral density loss with long-term use (>2 years). Use caution in adolescents and peri-menopausal women.
    • Weight gain, irregular bleeding, delayed return to fertility (up to 10-12 months after last injection).
  • Copper IUD (Paragard):
    • Side effects: heavier periods, longer menses, increased dysmenorrhea.
    • Best option for non-hormonal contraception and emergency contraception (up to 5 days post-unprotected intercourse).
  • LNG-IUS (Mirena, Kyleena, Skyla):
    • Common side effects: irregular bleeding/spotting in first 3-6 months, then often amenorrhea (especially Mirena).
    • Therapeutic uses: heavy menstrual bleeding, endometrial protection, dysmenorrhea.

Health Screening Prior to Contraceptive Initiation

Before initiating any contraceptive method, the FNP should perform a focused assessment. The mnemonic "BP, Hx, PE" is helpful for exam recall.

  1. Blood Pressure: Must be measured before starting CHC. Uncontrolled HTN (≥160/100) is a Category 4 contraindication.[1]
  2. History:
    • Age, smoking status, BMI.
    • Menstrual history: LMP, cycle regularity, dysmenorrhea, heavy bleeding.
    • Obstetric history: parity, recent pregnancy, breastfeeding.
    • Medical history: migraine (with/without aura), DVT/PE, HTN, liver disease, breast cancer, diabetes.
    • Medication list: Check for interactions (e.g., rifampin, certain anticonvulsants, St. John's wort decrease CHC efficacy).
    • Sexual history: STI risk, need for dual protection (condoms).
  3. Physical Exam:
    • Pelvic exam is NOT required before initiating most hormonal contraceptives (CDC guidelines). However, a Pap smear may be due based on age/cervical cancer screening guidelines.
    • Breast exam is not required before starting CHC, but clinical breast health should be addressed per screening guidelines.
    • Weight/BMI: Document for dosing reference (no method is contraindicated based on obesity alone, but efficacy of CHC may be slightly reduced in very high BMI).[1]
  4. Pregnancy Test: Obtain a urine hCG to rule out current pregnancy before initiating contraception. If negative, quick-start is appropriate.

Patient-Centered Method Selection and Initiation

Selecting a Method: Patient-Centered Approach

Use the "BRIDES" framework for shared decision-making during exam prep:

  • Benefits: What does the patient want? (e.g., lighter periods, fewer side effects, no hormones).
  • Reliability: How important is very high efficacy?
  • Interval: How long do they want protection? (e.g., IUD 5-10 years vs. monthly pill).
  • Discomfort tolerance: Are they okay with IUD insertion or DMPA injections?
  • Experience: Past success or failure with specific methods.
  • Side effect profile: Choose method aligned with patient's health concerns.

Step-by-Step: Initiating the Pill

  1. Confirm pregnancy test is negative.
  2. Rule out contraindications (especially migraine with aura, HTN, smoking age ≥35).
  3. Prescribe a month's supply initially; provide refills for 1 year.
  4. Instruct patient to start the first pill on the first day of next menses (Sunday-start or day-1 start).
  5. If quick-starting, instruct to use back-up contraception (condoms) for the first 7 days.
  6. Counsel on "ACHES" warning signs: Abdominal pain (thrombosis), Chest pain (PE), Headaches (migraine/HTN), Eye problems (stroke), Severe leg pain (DVT).
  7. Schedule follow-up in 3 months to assess adherence, side effects, and BP check.[5]

Emergency Contraception (EC) Quick Guide

  • Levonorgestrel (Plan B One-Step): Effective up to 72 hours. Works best within 24 hours. OTC, no age restriction. Efficacy decreases with time and with BMI > 26.
  • Ulipristal Acetate (Ella): Prescription only. Effective up to 120 hours (5 days). More effective than levonorgestrel in obese women. Superior to Plan B in the 72-120 hour window.
  • Copper IUD: Most effective EC (failure rate <1%). Can be placed up to 5 days after unprotected intercourse. Provides ongoing contraception for up to 10 years.[6]

Contraindication Profiles and Risk Mitigation

  • Thromboembolism (DVT/PE): Greatest risk with CHC, especially within first year of use. Risk is about 3-9 per 10,000 woman-years vs. 1-5 per 10,000 in non-users. Absolute risk is low but must be screened for.
  • Migraine with Aura: US MEC Category 4 for CHC at any age — this is a frequent exam point. The risk of ischemic stroke is elevated.
  • Breast Cancer: Current breast cancer is Category 4 for all hormonal methods. History of breast cancer but no evidence of current disease (5+ years) — Category 3 (risks usually outweigh benefits).
  • IUD Insertion Risks: Perforation of uterus (1 in 1,000 insertions), expulsion (2-10%), infection (rare <1% if screen for STIs before insertion).
  • DMPA and Bone Density: Use limited to 2 years unless other methods are contraindicated. Consider calcium and vitamin D supplementation.
  • Drug Interactions: Anticonvulsants (phenytoin, carbamazepine), rifampin, St. John's wort, certain protease inhibitors can reduce CHC efficacy. Advocate for LARC or DMPA in these patients.

Essential FNP Exam Priorities and Mnemonics

  • Know the US MEC Categories (1 = no restriction, 2 = benefits outweigh risks, 3 = risks usually outweigh benefits, 4 = unacceptable risk). For exam: migraine with aura + CHC = Category 4. Breastfeeding <6 weeks + CHC = Category 3.
  • LARC first line for adolescents and nulliparous women — CDC and ACOG recommend IUDs and implants as first-line for all ages, including teens.[3]
  • Obesity is NOT a contraindication to any contraceptive method. However, efficacy of oral pills and the patch may be slightly lower in women with BMI ≥ 30. LARC is preferred.
  • Dual protection reminder: Hormonal contraception does not prevent STIs. Always recommend condoms for STI prevention.
  • Quick-start is safe and effective — no need to wait for next menses if pregnancy is ruled out.
  • Memory Aid for CHC Contraindications: "SAFE" — Smoking age ≥35, Aura (migraine with aura), Fibroids? (no — only if submucosal or heavy bleeding with IUD), Estrogen-sensitive cancers, Embolism (DVT/PE history).
  • Return to fertility: Immediate after pills, patch, ring; variable after DMPA (average 10 months delay); immediate after IUD removal.
  • Missed pill rule: If a pill is missed for >48 hours, take the missed pill and use backup for 7 days. If missed in the last week of the cycle, skip the placebo week and start the next pack immediately.

References & Sources

  1. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. https://doi.org/10.15585/mmwr.rr7304a1
  2. Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008–2011. N Engl J Med. 2016;374:843-852. https://doi.org/10.1056/NEJMsa1506575
  3. American College of Obstetricians and Gynecologists. Long-Acting Reversible Contraception: Implants and Intrauterine Devices. ACOG Practice Bulletin No. 186. Obstet Gynecol. 2017;130:e251-e269. https://doi.org/10.1097/AOG.0000000000002400
  4. Hatcher RA, Trussell J, Nelson AL, et al. Contraceptive Technology. 22nd ed. New York, NY: Ayer Company Publishers; 2022. https://www.ncbi.nlm.nih.gov/books/NBK232749/
  5. Burns CE, Dunn AM, Brady MA, et al. Pediatric Primary Care. 7th ed. St. Louis, MO: Elsevier; 2020. (Chapter on contraception in adolescents) https://ocni.unap.edu.pe/scholarship/B12YN4/996209/burns_pediatric_primary_care_7th_edition.pdf
  6. Schuiling KD, Likis FE. Women's Gynecologic Health. 3rd ed. Burlington, MA: Jones & Bartlett Learning; 2017. (Contraception chapter) https://doi.org/10.12816/0040110

Ready to test your knowledge?

Master the core responsibilities, scope of practice, and limitations for the Family Nurse Practitioner exam.

Start Practice Questions
Previous Topic Next Topic